Cargando…

Peripheral T-Cell Lymphomas: Therapeutic Approaches

SIMPLE SUMMARY: Peripheral T-cell lymphomas are a group of rare cancers of T cells or natural killer cells, most often with a poor prognosis. In recent years, significant progress has been made through the development of more specific therapies. This review aims to provide an up-to-date overview of...

Descripción completa

Detalles Bibliográficos
Autor principal: Sibon, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104854/
https://www.ncbi.nlm.nih.gov/pubmed/35565460
http://dx.doi.org/10.3390/cancers14092332
_version_ 1784707896436588544
author Sibon, David
author_facet Sibon, David
author_sort Sibon, David
collection PubMed
description SIMPLE SUMMARY: Peripheral T-cell lymphomas are a group of rare cancers of T cells or natural killer cells, most often with a poor prognosis. In recent years, significant progress has been made through the development of more specific therapies. This review aims to provide an up-to-date overview of current treatments in nodal PTCL. ABSTRACT: Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare neoplasms of mature T cells or natural killer (NK) cell. PTCLs usually have an aggressive course and a poor outcome. In recent years, significant progress has been made in the knowledge of the molecular lymphomagenesis of PTCLs, and through the development of new, more specific therapeutic molecules, one can hope in the coming years for more personalized medicine and improved patient prognosis. This review aims to provide an up-to-date overview of the current therapeutic approaches in nodal PTCLs.
format Online
Article
Text
id pubmed-9104854
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91048542022-05-14 Peripheral T-Cell Lymphomas: Therapeutic Approaches Sibon, David Cancers (Basel) Review SIMPLE SUMMARY: Peripheral T-cell lymphomas are a group of rare cancers of T cells or natural killer cells, most often with a poor prognosis. In recent years, significant progress has been made through the development of more specific therapies. This review aims to provide an up-to-date overview of current treatments in nodal PTCL. ABSTRACT: Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of rare neoplasms of mature T cells or natural killer (NK) cell. PTCLs usually have an aggressive course and a poor outcome. In recent years, significant progress has been made in the knowledge of the molecular lymphomagenesis of PTCLs, and through the development of new, more specific therapeutic molecules, one can hope in the coming years for more personalized medicine and improved patient prognosis. This review aims to provide an up-to-date overview of the current therapeutic approaches in nodal PTCLs. MDPI 2022-05-08 /pmc/articles/PMC9104854/ /pubmed/35565460 http://dx.doi.org/10.3390/cancers14092332 Text en © 2022 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sibon, David
Peripheral T-Cell Lymphomas: Therapeutic Approaches
title Peripheral T-Cell Lymphomas: Therapeutic Approaches
title_full Peripheral T-Cell Lymphomas: Therapeutic Approaches
title_fullStr Peripheral T-Cell Lymphomas: Therapeutic Approaches
title_full_unstemmed Peripheral T-Cell Lymphomas: Therapeutic Approaches
title_short Peripheral T-Cell Lymphomas: Therapeutic Approaches
title_sort peripheral t-cell lymphomas: therapeutic approaches
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104854/
https://www.ncbi.nlm.nih.gov/pubmed/35565460
http://dx.doi.org/10.3390/cancers14092332
work_keys_str_mv AT sibondavid peripheraltcelllymphomastherapeuticapproaches